Member login | Not a member? Sign up
ReNeuron Group develops therapies and treatments using stem cells. ReNeuron originally joined Aim in 2000 and was taken private again in 2003. ReNeuron rejoined Aim on 12 August 2005 having raised £9.5m at 25p a share.
betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology
Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds